Literature DB >> 9390851

Temperature correction of blood gas values.

B A Shapiro1.   

Abstract

The popularity of routine temperature correcting of pH, PCO2 and PO2 values is based on the observation that large differences in the blood gas values are present when the patient's temperature is profoundly hypo- or hyperthermic. This observation leads some clinicians to the unsubstantiated conclusion that uncorrected 37 degrees C values are "wrong." The danger in this superficial thought process is that one might reach the unfounded conclusion that temperature-corrected values are "right." The simple truth is: With significant changes in patient temperature, we do not fully understand the complexity of the effects on metabolism, vascular function, and respiration. Both corrected and uncorrected blood gas values, therefore, are of uncertain usefulness in patients with significant deviations in body temperature. There is no logical or scientific basis for the assumption that temperature-corrected values are better than the values obtained at 37 degrees C. In fact, the available technical and biological data lead to the conclusion that, in almost all circumstances, there is no clinical advantage to using values other than those at 37 degrees C. In addition, the routine process of temperature correction of blood gases involves several practical disadvantages. First, interpretation of the corrected values demands deviation from the familiar and well-documented guidelines for interpreting 37 degrees C values. Second, temperature correction assumes the laboratory has received the patient's true temperature at the time of sampling. My experience is that the patient's true temperature often is not reported or is reported erroneously. Third, temperature-corrected values can be confused with uncorrected values and vice versa. Available data support the practice that only uncorrected (37 degrees C) blood gas values should be used and reported routinely. Temperature-corrected values should be calculated only when specifically requested and the onus for clinical use of temperature-corrected values lies with the clinician who requests them.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9390851

Source DB:  PubMed          Journal:  Respir Care Clin N Am        ISSN: 1078-5337


  8 in total

Review 1.  Essentials of Hyperbaric Oxygen Therapy: 2019 Review.

Authors:  John P Kirby; Jason Snyder; Douglas J E Schuerer; John S Peters; Grant V Bochicchio
Journal:  Mo Med       Date:  2019 May-Jun

2.  Targeting hypoxia in the leukemia microenvironment.

Authors:  Juliana Benito; Zhihong Zeng; Marina Konopleva; William R Wilson
Journal:  Int J Hematol Oncol       Date:  2013-08-01

3.  Surrogate scale for evaluating respiratory function based on complete blood count parameters.

Authors:  Yang Guang; Zhou Jie; Dong Feng; Liu Hui
Journal:  J Clin Lab Anal       Date:  2018-01-15       Impact factor: 2.352

4.  Simultaneous measurement of brain tissue oxygen partial pressure, temperature, and global oxygen consumption during hibernation, arousal, and euthermy in non-sedated and non-anesthetized Arctic ground squirrels.

Authors:  Yilong Ma; Shufen Wu
Journal:  J Neurosci Methods       Date:  2008-07-25       Impact factor: 2.390

5.  Therapeutic peritoneal lavage with warm saline solution as an option for a critical hypothermic trauma patient.

Authors:  Thomas Freude; Sonja Gillen; Sabrina Ehnert; Andreas Nüssler; Ulrich Stöckle; Natascha Charalambakis; Stefan Döbele; Stefan Pscherer
Journal:  Wien Klin Wochenschr       Date:  2013-11-19       Impact factor: 1.704

6.  Effects of time delay and body temperature on measurements of central venous oxygen saturation, venous-arterial blood carbon dioxide partial pressures difference, venous-arterial blood carbon dioxide partial pressures difference/arterial-venous oxygen difference ratio and lactate.

Authors:  Xiang-Yu Wan; Li-Li Wei; Yan Jiang; Ping Li; Bo Yao
Journal:  BMC Anesthesiol       Date:  2018-12-11       Impact factor: 2.217

Review 7.  Hypoxia and the phenomenon of immune exclusion.

Authors:  Violena Pietrobon; Francesco M Marincola
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

8.  Point-of-care viscoelastic coagulation assessment in healthy dogs during the perianesthetic period.

Authors:  Wen H Wang; Alex M Lynch; Julie A Balko; Daniel J Duffy; James B Robertson; Lysa P Posner
Journal:  BMC Vet Res       Date:  2022-09-14       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.